Michael J. Owen is a co-founder and former CSO of Kymab Ltd. Before joining Kymab, he held several leading positions at GlaxoSmithKline, latterly as SVP and head of biopharmaceuticals research. Prior to joining GSK in 2001, he headed the Lymphocyte Molecular Biology group at the Imperial Cancer Research Fund. He has more than 20 years' research experience with a focus on the immune system.Michael J. Owen is board member of Blink Biomedical SAS, Ossianix, Inc., Avacta Group plc, ReNeuron Group. Plc and GammaDelta Therapeutics. He is also adviser to Kymab Ltd and CRT Pioneer Fund LP.
Management